Buradasınız

Anasayfa » Content

Renal Replasman Tedavisi Alan Hastaların Hastaneye Yatış ve Sağkalım Açısından Karşılaştırılması

Comparison of Hospitalization and Survival Between Patients Treated With Renal Replacement Therapy

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2011
DOI: 
DOI 10.5262/tndt.2011.1001.12

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
AIM : Renal replacement therapy (RRT) prolongs survival in patients with end-stage-renal-disease (ESRD). We compared patient survival, number and duration of hospitalization in patients treated with RRT in this study. MA TERIAL and M ETHODS: Two hundred and eighty seven patients (87 hemodialysis (HD), 97 peritoneal dialysis (PD), 103 renal transplant (RT) patients) were enrolled in this study. Patients’ data were collected retrospectively from hospital records. RESUL TS: HD patients were older and had more comorbid diseases compared to PD and RT patients. Mortality rates were not different between the modalitites. The number and duration of hospitalization episodes were significantly lower in the PD group than that of the other two groups. Survival rates of HD patients were 84%, 55% and 30% for the 1st, 5th and 10th years, respectively while these rates were 93%, 81% and 59% for PD and 95%, 81% and 77% for RT patients. CONCLU SION: PD and RT patients were younger than HD patients and had less comorbid diseases. As a result, the number and duration of hospitalization episodes were significantly lower in the PD group when compared to the others. Survival rates in the RT group were better than that of the HD and PD groups.
Bookmark/Search this post with
Abstract (Original Language): 
AMA Ç: Böbrek yerine koyma tedavisi son dönem böbrek yetmezliği (SDBY) hastalarında yaşam süresini uzatmaktadır. Biz bu çalışmada, SDBY hastalarında böbrek yerine koyma tedavisi sağkalım, hastaneye yatış sıklığı ve hastanede kalış süresi üzerine olan etkilerini karşılaştırmayı amaçladık. GEREÇ ve YÖN TEML ER: İki yüz seksen yedi (87 hemodiyaliz (HD), 97 periton diyalizi (PD), 103 böbrek nakli (BN)) hastası çalışmaya alındı. Hasta verileri geriye dönük olarak hasta dosyalarından kaydedildi. BUL GULA R: Hemodiyaliz hastalarının PD ve BN hastalarına oranla daha yaşlı ve daha fazla yandaş hastalığa sahip oldukları görüldü. Her 3 grupta mortalite oranları bakımından farklılık saptanmadı. PD grubunda hastaneye yatış sıklığı ve hastanede kalış süresi diğer iki gruba oranla daha düşüktü. 1, 5, 10 yıllık hasta sağ kalımları HD grubunda %84, %55, %30 iken, PD grubunda %93, %81, %59, BN grubunda ise %95, %81 ve %77 olarak bulundu. SONU Ç: PD ve RT hastaları HD hastalarına oranla daha genç, HD hastaları daha fazla ek hastalığa sahip, PD hastalarında hastaneye yatış oranı daha az iken en iyi hasta sağ kalımı ise BN grubundadır.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_20_pp_72-76.pdf
  • 1
72-76
  • Turkish

REFERENCES

References: 

1. James MT, Hemmelgarn BR, Tonelli M: Early recognition
and prevention of chronic kidney disease. Lancet 2010; 375:
1296-1309
2. Ruggenenti P, Schiepattati A, Remuzzi G: Progression, remission,
regression of chronic renal disease. Lancet 2001; 357: 1601-1608
3. Johnson JG, Gore SM, Firth J: The effect of age, diabetes and other
comorbidity on the survival of patients on dialysis: A systematic
quantitative overview of the literature. Nephrol Dial Transplant
1999; 14: 2156-2164
4. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS,
MacLeod AM: Influence of coexisting disease on survival on renalreplacement
therapy. Lancet 1993; 341: 415-418
5. Letorneau I, Quimet D, Dumont M, Pichette V, Leblanc M: Renal
replacement in end-stage renal disease patients over 75 years old.
Am J Nephrol 2003; 23: 71-77
6. Ponikvar R, Ponikvar JB: Management of diabetic patients with
hemodialysis, peritoneal dialysis and renal transplantation. Nephrol
Dial Transplant 2001; 16: 94-96
7. Rodriquez JA, Cleries M, Vela E: Renal registry committee. Diabetic
patients on renal replacement therapy: Analysis of Catalan Registry
data. Nephrol Dial Transplant 1997; 12: 2501-2509
8. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe
RA: Continuous ambulatory peritoneal dialysis and hemodialysis:
Comparison of patient mortality with adjustment for comorbid
conditions. Kidney Int 1994; 45: 1163-1169
9. Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS,
Meyer KB, Pereira BJ: Hospital utilization among chronic dialysis
patients. J Am Soc Nephrol 2000; 11: 740-746
10. Levin A: The role of anemia in the genesis of cardiac abnormalities
in patients with chronic kidney disease. Nephrol Dial Transplant
2002; 17(2): 207-210
11. Vonesh EF, Moran J: Mortality in end-stage renal disease:
A reassessment of differences between patients treated with
hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10:
354-365
12. Maiorca R, Cancarini GC, Zubani R, Movilli E, Brunori G: Differing
dialysis treatment strategies and outcome. Nephrol Dial Transplant
1996; 11: 2324-2331
13. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS,
Avorn J: Comparing mortality of elderly patients on hemodialysis
versus peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177-183
14. Heaf JG, Lokkegaard H, Madsen M: Initial survival advantage of
peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant
2002; 17: 112-117
15. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison
of survival probabilities for dialysis patients versus cadaveric renal
transplant recipients. JAMA 1993; 270: 1339-1343
16. McDonald S, Russ GR: Survival of recipients of cadaveric kidney
transplants compared with those receiving dialysis treatment in
Australia and New Zeland,1991-2001. Nephrol Dial Transplant
2002; 17: 2212-2219
17. Metcalfe W, Khan IH, Prescott GJ, Simpson K, Macleod AM:
Hospitalization in the first year of renal replacement therapy for
end-stage renal disease. QJ Med 2003; 96: 899-909
18. Locatelli F, Pozzoni P, Tentori F, Del Vecchio L: Epidemiology of
cardiovascular risk in patients with chronic kidney disease. Nephrol
Dial Transplant 2003; 18( Supp 7): vii2-vii9
19. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire
N: Chronic kidney disease as cause of cardiovascular morbidity and
mortality. Nephrol Dial Transplant 2005; 20: 1048-1056
20. García-López E, Carrero JJ, Suliman ME, Lindholm B, Stenvinkel
P: Risk factors for cardiovascular disease in patients undergoing
peritoneal dialysis. Perit Dial Int 2007; Suppl 2: S205-209
21. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG,
Ma JZ: Mortality risk of peritoneal dialysis and hemodialysis. Am J
Kidney Dis 1999; 34: 1065-1074
22. Schaubel DE, Morrison HI, Fenton SSA: Comparing mortality rates
on CAPD/CCPD and hemodialysis. The Canadian experience: Fact
or fiction? Perit Dial Int 1998; 18: 478-484
23. Wolfe RA, Ashby VB, Milfort EL, Ojo AO, Ettenger RE, Agodoa
LY, Held PJ, Port FK: Comparison of mortality in all patients on
dialysis, patients on dialysis awaiting transplantation, and recipients
of a first cadaveric transplant. N Eng J Med 1999; 341: 1725-1730

Thank you for copying data from http://www.arastirmax.com